Abstract As of 25 January 2022, over 349 million individuals have received a confirmed
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …

A subgroup of patients infected with SARS-CoV-2 remain symptomatic over three months
after infection. A distinctive symptom of patients with long COVID is post-exertional malaise …

Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …

The ongoing coronavirus disease 2019 (COVID-19) pandemic highlights the importance of
developing point-of-care (POC) antibody tests for monitoring the COVID-19 immune …

Robust population-wide immunity will help to curb the SARS-CoV-2 pandemics. To maintain
the immunity at protective levels, the quality and persistence of the immune response …

Background In settings where the COVID-19 vaccine supply is constrained, extending the
intervals between the first and second doses of the COVID-19 vaccine may allow more …

Background This prospective cohort study aimed to evaluate the antibody responses in non‐
invasive gingival crevicular fluid (GCF) and unstimulated whole saliva to the SARS‐CoV‐2 …

Background Safe and effective vaccines against COVID-19 are critical for preventing the
spread of SARS-CoV-2, but little is known about the humoral immune response more than 9 …

Objectives Preventive measures against COVID-19 are essential for pregnant women.
Pregnant women are particularly vulnerable to emerging infectious pathogens due to …

SARS-CoV-2-specific antibodies are secreted into human milk of infected or vaccinated
lactating women and might provide protection to the breastfed infant against COVID-19 …